SCHEMBL30890751

SCHEMBL30890751

CCCCOC(=O)N1C(=O)C(C(=O)OCC)C[C@H]1C(=O)OCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
L3MBTL1 Q9Y468 3/20 0.38
HPGD P15428 2/20 0.38
ATM Q13315 1/20 0.38
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
POLB P06746 2/20 0.37
LMNA P02545 2/20 0.37
KDM4E B2RXH2 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPK1 P28482 1/20 0.35
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
HSP90AA1 P07900 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30992286 0.80 MAPT (0.44) ALDH1A1HPGDMAPTLMNAKDM4E
SCHEMBL1568510 0.77 ALDH1A1 (0.38) ALDH1A1L3MBTL1HPGDATMSMN1; SMN2
SCHEMBL7452525 0.75 MAPT (0.36) ALDH1A1HPGDMAPTLMNAKDM4E
SCHEMBL30445758 0.74 MAPT (0.41) ALDH1A1HPGDMAPTKDM4EMEN1
SCHEMBL30541889 0.74 MAPT (0.40) ALDH1A1L3MBTL1HPGDMAPTSMN1; SMN2
SCHEMBL10435133 0.73 L3MBTL1 (0.36) ALDH1A1L3MBTL1HPGDATMSMN1; SMN2
SCHEMBL9635638 0.70 GBA2 (0.44) ALDH1A1L3MBTL1HPGDATMSMN1; SMN2
SCHEMBL9635642 0.70 GBA2 (0.44) ALDH1A1L3MBTL1HPGDATMSMN1; SMN2
SCHEMBL533925 0.70 LMNA (0.45) ALDH1A1L3MBTL1HPGDATMMAPT
SCHEMBL23922737 0.69 LMNA (0.34) ALDH1A1MAPTSMN1; SMN2POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 WO disclosed